Close Menu

NEW YORK — Canopy Biosciences said today it has acquired biopharma services firm Core Diagnostics.

With the purchase, St. Louis, Missouri-based Canopy acquires Core's CLIA facility, from which it will provide its multi-omic immune profiling services.

Core also offers NanoString transcriptional profiling and histopathology services including immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH).

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.